HGH Fragment 176–191 is a synthetic peptide, a small piece of human growth hormone (HGH) focused on fat metabolism, known to promote fat breakdown (lipolysis) and hinder fat storage (lipogenesis), often used in research for weight management and body sculpting, though not extensively studied in humans like its related compound, AOD9604, but shows promise in lab settings, including potential anti-cancer applications when combined with other therapies.
What it Is
- A 15-amino acid peptide derived from the C-terminal region (amino acids 176-191) of HGH.
- It’s designed to mimic HGH’s fat-reducing effects without causing the growth-promoting side effects of full HGH.
How it Works (Proposed Mechanisms)
- Stimulates Lipolysis: Breaks down stored body fat.
- Inhibits Lipogenesis: Prevents the creation of new fat.
- Preserves Muscle: Helps in reducing body fat while maintaining lean muscle mass.
- Adrenergic Pathway: Research suggests it may work by increasing the activity of beta-3 adrenergic receptors, which are heavily involved in burning fat in humans.
For research use only, not to be used in clinical trials involving humans. Documentation is for information only.
